行情

ORMP

ORMP

Oramed制药
NASDAQ

实时行情|Nasdaq Last Sale

8.92
-1.01
-10.13%
盘后: 8.90 -0.02 -0.17% 16:37 01/21 EST
开盘
9.61
昨收
9.92
最高
9.85
最低
8.76
成交量
167.97万
成交额
--
52周最高
31.54
52周最低
4.235
市值
3.40亿
市盈率(TTM)
-11.6338
分时
5日
1月
3月
1年
5年
Oramed 向股东发布年度讯息
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today issued a Letter to Shareholders from its Chief Executive Officer, Nadav Kidron. To see a vide...
PR Newswire · 01/12 13:45
BRIEF-Oramed Granted Key European Patent For Platform Technology In Oral Delivery Of Proteins
reuters.com · 01/05 12:49
Oramed Granted Key European Patent for Platform Technology in Oral Delivery of Proteins
Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, today announced the European Patent Office has granted the Company a patent titled "Protea...
PR Newswire · 01/05 12:30
BRIEF-Mymd Pharmaceuticals Investment Company Oravax Medical Signs Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10 Million Doses Of Oral Covid-19 Vaccine To Be Commercialized In Southeast Asia
reuters.com · 2021/12/29 14:23
MyMD Pharmaceuticals Highlights Investment Company Oravax Medical's Cooperation And Purchase Agreement For Initial Pre-Purchase Of 10M Doses Of Oral COVID-19 Vaccine To Be Commercialized In Southeast Asia
In addition to pre-purchase order, parties have agreed to negotiate potential follow-on orders that could be significant MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) ("MyMD" or "the Company"), a
Benzinga · 2021/12/29 14:16
Oramed's subsidiary inks purchase deal for 10M doses of oral COVID-19 vaccines in Southeast Asia
Oramed Pharmaceuticals' (NASDAQ:ORMP) subsidiary, Oravax Medical, has signed a Cooperation and Purchase Agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Company to pre-purchase Oravax's oral COVID-19 vaccine, currently in
Seekingalpha · 2021/12/29 11:29
Oramed's Oravax sub signs pre-purchase agreement for 10 million oral COVID-19 vaccines with Tan Thanh
Oramed Pharmaceuticals Inc. said Wednesday its Oravax Medical subsidiary has signed an agreement with Vietnam-based Tan Thanh Holdings Investment Joint Stock Co. to pre-purchase 10 million doses of Oravax's oral COVID-19 vaccines in development. The drug m...
marketwatch.com · 2021/12/29 11:14
BRIEF-Oramed Subsidiary Oravax Medical Signs Deal For An Initial Pre-Purchase Of 10 Mln Doses Of Oral COVID-19 Vaccines With Tan Thanh Holdings To Commercialize In Southeast Asia
reuters.com · 2021/12/29 11:05
更多
财务预测
实际值（美元）
预测值（美元）
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解ORMP最新的财务预测，通过ORMP每股收益，每股净资产，每股现金流等数据分析Oramed制药近期的经营情况，然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

买入

免责声明：分析师观点仅供投资者决策参考，不构成任何买卖投资建议。

25.00%强力推荐
75.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测ORMP价格均价为33.00，最高价位40.00，最低价为23.00。
最高40.00
均价33.00
最低23.00
现价8.92
EPS
实际EPS
预期EPS
-0.18-0.13-0.09-0.04
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 103
机构持股: 587.67万
持股比例: 15.43%
总股本: 3,808.60万
类型机构数股数
增持
40
154.70万
建仓
26
111.46万
减持
13
23.22万
平仓
7
13.36万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-1.82%
制药与医学研究
-1.11%
高管信息
Non-Executive Chairman/Independent Director
Kevin Rakin
Chief Executive Officer/President/Director
Nadav Kidron
Chief Financial Officer/Treasurer
David Silberman
Chief Operating Officer
Joshua Hexter
Chief Scientific Officer/Director
Miriam Kidron
General Counsel/Secretary
Netanel Derovan
Other
Michael Rabinowitz
Independent Director
Aviad Friedman
Independent Director
Arie Mayer
Independent Director
Leonard Sank
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
ORMP 简况
Oramed Pharmaceuticals Inc.是一家制药公司。该公司从事药物溶液的研发业务，包括治疗糖尿病个体的口服胰岛素胶囊以及递送其他多肽的口服可摄取胶囊或丸剂。该公司的旗舰产品ORMD-0801是一种口服可摄取胰岛素胶囊。截至2016年8月31日，该公司已完成治疗2型糖尿病的ORMD-0801 的第二b期临床试验。胰高血糖素样肽-1（GLP-1）是一种肠促胰岛素激素，即一种刺激胰腺分泌胰岛素的胃肠类激素。该公司的其他产品是口服可摄取GLP-1胶囊ORMD-0901。截至2016年8月31日，ORMD-0901处于治疗2型糖尿病第一期临床试验。

微牛提供Oramed Pharmaceuticals, Inc.(NASDAQ-ORMP)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的ORMP股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ORMP股票基本功能。